UroGen Pharma
URGN
URGN
79 hedge funds and large institutions have $250M invested in UroGen Pharma in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 86 → 79 (-7)
47% less capital invested
Capital invested by funds: $473M → $250M (-$223M)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
79
Holding in Top 10
2
Calls
$4.89M
Puts
$3.55M
Top Buyers
| 1 | +$9.13M | |
| 2 | +$5.47M | |
| 3 | +$4.83M | |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
+$2.68M |
| 5 |
HCM
Horton Capital Management
Philadelphia,
Pennsylvania
|
+$2.55M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$7.41M | |
| 3 | -$4.56M | |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$4.32M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$2.83M |